Application of next-generation sequencing in the diagnosis of gastric cancer

References

• Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26–38.
   PubMed Web of Science ®Google Scholar
• Sexton RE, Al Hallak MN, Diab M, et al. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39(4):1179–1203.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Washington MK, Goldberg RM, Chang GJ, WHO Classification of Tumours Editorial Board, et al. Diagnosis of digestive system tumours. Int J Cancer. 2021;148(5):1040–1050.
   PubMed Web of Science ®Google Scholar
• Nagtegaal ID, Odze RD, Klimstra D, WHO Classification of Tumours Editorial Board, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182–188.
   PubMed Web of Science ®Google Scholar
• de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607–615.
   PubMed Web of Science ®Google Scholar
• Pormohammad A, Ghotaslou R, Leylabadlo HE, et al. Risk of gastric cancer in association with Helicobacter pylori different virulence factors: a systematic review and meta-analysis. Microbial Pathogenesis. 2018;118:214–219.
   PubMed Web of Science ®Google Scholar
• Ignatova E, Seriak D, Fedyanin M, et al. Epstein-Barr virus-associated gastric cancer: disease that requires special approach . Gastric Cancer. 2020;23(6):951–960.
   PubMed Web of Science ®Google Scholar
• Chen Y-C, Fang W-L, Wang R-F, et al. Clinicopathological variation of lauren classification in gastric cancer. Pathol Oncol Res. 2016;22(1):197–202.
   PubMed Web of Science ®Google Scholar
• Hu B, El Hajj N, Sittler S, et al. Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3(3):251–261.
   PubMedGoogle Scholar
• Wang Q, Liu G, Hu C. Molecular classification of gastric adenocarcinoma. Gastroenterol Res. 2019;12(6):275–282.
   PubMed Web of Science ®Google Scholar
• Wang F-H, Shen L, Li J, et al. The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Commun (Lond). 2019;39(1):1–31.
   PubMed Web of Science ®Google Scholar
• Verma R, Sharma PC. Next generation sequencing-based emerging trends in molecular biology of gastric cancer. Am J Cancer Res. 2018;8(2):207–225.
   PubMed Web of Science ®Google Scholar
• Biesecker LG, Shianna KV, Mullikin JC. Exome sequencing: the expert view. Genome Biol. 2011;12(9):128.
   PubMed Web of Science ®Google Scholar
• Belkadi A, Bolze A, Itan Y, et al. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants. Proc Natl Acad Sci U S A. 2015;112(17):5473–5478.
   PubMed Web of Science ®Google Scholar
• Retterer K, Juusola J, Cho MT, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. 2016;18(7):696–704.
   PubMed Web of Science ®Google Scholar
• Iglesias A, Anyane-Yeboa K, Wynn J, et al. The usefulness of whole-exome sequencing in routine clinical practice. Genet Med. 2014;16(12):922–931.
   PubMed Web of Science ®Google Scholar
• Tan TY, Dillon OJ, Stark Z, et al. Diagnostic impact and cost-effectiveness of Whole-Exome sequencing for ambulant children with suspected monogenic conditions. JAMA Pediatr. 2017;171(9):855–862.
   PubMed Web of Science ®Google Scholar
• Best S, Wou K, Vora N, et al. Promises, pitfalls and practicalities of prenatal whole exome sequencing. Prenat Diagn. 2018;38(1):10–19.
   PubMed Web of Science ®Google Scholar
• Ghazani AA, Oliver NM, St. Pierre JP, et al. Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study. Genet Med. 2017;19(7):787–795.
   PubMed Web of Science ®Google Scholar
• Shi W, Ng CKY, Lim RS, et al. Reliability of Whole-Exome sequencing for assessing intratumor genetic heterogeneity. Cell Rep. 2018;25(6):1446–1457.
   PubMed Web of Science ®Google Scholar
• Schneider BP, Stout LA, Philips S, et al. Implications of incidental germline findings identified in the context of clinical whole exome sequencing (WES) for guiding cancer therapy. J Clin Oncol. 2019;37(15_suppl):1581–1581.
   Web of Science ®Google Scholar
• Zare F, Dow M, Monteleone N, et al. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data. BMC Bioinformatics. 2017;18(1):1–13.
   PubMed Web of Science ®Google Scholar
• Koeppel F, Blanchard S, Jovelet C, et al. Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients. PLoS ONE. 2017;12(11):e0188174.
   PubMed Web of Science ®Google Scholar
• Gilissen C, Hehir-Kwa JY, Thung DT, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511(7509):344–347.
   PubMed Web of Science ®Google Scholar
• Nones K, Waddell N, Wayte N, et al. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nat Commun. 2014;5(1):1–9.
   Web of Science ®Google Scholar
• van El CG, Cornel MC, Borry P, on behalf of the ESHG Public and Professional Policy Committee, et al. Whole-genome sequencing in health care. Recommendations of the European society of human genetics. Eur J Hum Genet. 2013;21(6):580–585.
   PubMed Web of Science ®Google Scholar
• Trost B, Walker S, Wang Z, et al. A comprehensive workflow for read depth-based identification of copy-number variation from whole-genome sequence data. Am J Human Genet. 2018;102(1):142–155.
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Fujita M. Whole genome sequencing analysis for cancer genomics and precision medicine. Cancer Sci. 2018;109(3):513–522.
   PubMed Web of Science ®Google Scholar
• Meienberg J, Bruggmann R, Oexle K, et al. Clinical sequencing: is WGS the better WES? Hum Genet. 2016;135(3):359–362.
   PubMed Web of Science ®Google Scholar
• Mattick JS, Dinger M, Schonrock N, et al. Whole genome sequencing provides better diagnostic yield and future value than whole exome sequencing. Med J Aust. 2018;209(5):197–199.
   PubMed Web of Science ®Google Scholar
• Carss K, Arno G, Erwood M, et al. Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease. Am J Human Genet. 2016;100(1):75–90.
   PubMed Web of Science ®Google Scholar
• Davies H, Morganella S, Purdie CA, et al. Whole-Genome sequencing reveals breast cancers with mismatch repair deficiency. Cancer Res. 2017;77(18):4755–4762.
   PubMed Web of Science ®Google Scholar
• Greer SU, Nadauld LD, Lau BT, et al. Linked read sequencing resolves complex genomic rearrangements in gastric cancer metastases. Genome Med. 2017;9(1):1–17.
   PubMed Web of Science ®Google Scholar
• Cavalcante GC, Marinho ANR, Anaissi AK, et al. Whole mitochondrial genome sequencing highlights mitochondrial impact in gastric cancer. Sci Rep. 2019;9(1):1–13.
   PubMed Web of Science ®Google Scholar
• Neiman M, Taylor DR. The causes of mutation accumulation in mitochondrial genomes. Proceedings of the Royal Society. Proc Biol Sci. 2009;276(1660):1201–1209.
   PubMed Web of Science ®Google Scholar
• Stefania W, Angelo P, Stefania T. Mitochondria and familial predisposition to breast cancer. Curr Genomics. 2013;14(3):195–203.
   PubMed Web of Science ®Google Scholar
• Saranathan R, Levi MH, Wattam AR, et al. Helicobacter pylori infections in the Bronx, New York: surveying antibiotic susceptibility and strain lineage by whole-genome sequencing. J Clin Microbiol. 2020;58(3):e01591–e01519.
   PubMed Web of Science ®Google Scholar
• Camargo MC, Bowlby R, Chu A, et al. Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in the cancer genome atlas. Gastric Cancer. 2016;19(2):676–681.
   PubMed Web of Science ®Google Scholar
• Bustos-Carpinteyro AR, Oliveira C, Sousa A, et al. CDH1 somatic alterations in mexican patients with diffuse and mixed sporadic gastric cancer. BMC Cancer. 2019;19(1):1–9.
   PubMed Web of Science ®Google Scholar
• Kuboki Y, Yamashita S, Niwa T, et al. Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer. Ann Oncol. 2016;27(1):127–133.
   PubMed Web of Science ®Google Scholar
• Mafficini A, Amato E, Fassan M, et al. Reporting tumor molecular heterogeneity in histopathological diagnosis. PLoS ONE. 2014;9(8):e104979.
   PubMed Web of Science ®Google Scholar
• Vecchi M, Nuciforo P, Romagnoli S, et al. Gene expression analysis of early and advanced gastric cancers. Oncogene. 2007;26(29):4284–4294.
   PubMed Web of Science ®Google Scholar
• Marimuthu A, Jacob HKC, Jakharia A, et al. Gene expression profiling of gastric cancer. J Proteomics Bioinform. 2011;4(4):74–82.
   PubMedGoogle Scholar
• Sun H. Identification of key genes associated with gastric cancer based on DNA microarray data. Oncol Lett. 2016;11(1):525–530.
   PubMed Web of Science ®Google Scholar
• Chu Y, Corey DR. RNA sequencing: platform selection, experimental design, and data interpretation. Nucleic Acid Ther. 2012;22(4):271–274.
   PubMed Web of Science ®Google Scholar
• Heo YJ, Park C, Yu D, et al. Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue. Sci Rep. 2019;9(1):9675.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhao X, Shao Z. A system level analysis of gastric cancer across tumor stages with RNA-seq data. Mol BioSyst. 2015;11(7):1925–1932.
   PubMedGoogle Scholar
• Fu K, Hui B, Wang Q, et al. Single-cell RNA sequencing of immune cells in gastric cancer patients. Aging (Albany, NY). 2020;12(3):2747–2763.
   PubMedGoogle Scholar
• Singh BP, Gupta VK. Molecular markers in mycology. Switzerland: Springer International Publishing; 2017.
   Google Scholar
• Xiao W, Wu L, Yavas G, et al. Challenges, solutions, and quality metrics of personal genome assembly in advancing precision medicine. Pharmaceutics. 2016;8(2):15.
   PubMed Web of Science ®Google Scholar
• Kumar S, Krishnani KK, Bhushan B, et al. Metagenomics: retrospect and prospects in high throughput age. Biotechnol Res Int. 2015;2015:1–13.
   Google Scholar
• Rizzato C, Torres J, Obazee O, et al. Variations in cag pathogenicity island genes of Helicobacter pylori from Latin American groups may influence neoplastic progression to gastric cancer. Sci Rep. 2020;10(1):6570.
   PubMed Web of Science ®Google Scholar
• Rizzato C, Torres J, Plummer M, et al. Variations in Helicobacter pylori cytotoxin-associated genes and their influence in progression to gastric cancer: implications for prevention. PLoS ONE. 2012;7(1):e29605.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Andersson AF, Ye W, et al. A method for metagenomics of Helicobacter pylori from archived formalin-fixed gastric biopsies permitting longitudinal studies of carcinogenic risk. PloS One. 2011;6(10):e26442.
   PubMed Web of Science ®Google Scholar
• Sohn S-H, Kim N, Jo HJ, et al. Analysis of gastric body microbiota by pyrosequencing: possible role of bacteria other than Helicobacter pylori in the gastric carcinogenesis. J Cancer Prev. 2017;22(2):115–125.
   PubMed Web of Science ®Google Scholar
• Sung J, Kim N, Kim J, et al. Comparison of gastric microbiota between gastric juice and mucosa by next generation sequencing method. J Cancer Prev. 2016;21(1):60–65.
   PubMedGoogle Scholar
• Eun CS, Kim BK, Han DS, et al. Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods. Helicobacter. 2014;19(6):407–416.
   PubMed Web of Science ®Google Scholar
• Hu Z, Cheng L, Wang H. The Illumina-Solexa sequencing protocol for bacterial genomes. In: Mengoni A, Galardini M, Fondi M, editors. Bacterial pangenomics: methods and protocols. New York (NY): Springer New York; 2015. p. 91–97.
   Google Scholar
• Pettersson E, Lundeberg J, Ahmadian A. Generations of sequencing technologies. Genomics. 2009;93(2):105–111.
   PubMed Web of Science ®Google Scholar
• Asakawa Y, Okabe A, Fukuyo M, et al. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3. Cancer Sci. 2020;111(5):1818–1828.
   PubMed Web of Science ®Google Scholar
• Ito T, Matoba R, Maekawa H, et al. Detection of gene mutations in gastric cancer tissues using a commercial sequencing panel. Mol Clin Oncol. 2019;11(5):455–460.
   PubMed Web of Science ®Google Scholar
• Castaño-Rodríguez N, Goh K-L, Fock KM, et al. Dysbiosis of the microbiome in gastric carcinogenesis. Sci Rep. 2017;7(1):15957.
   PubMed Web of Science ®Google Scholar
• Qi Y, Ooi HS, Wu J, et al. MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10. Oncotarget. 2016;7(11):12693–12703.
   PubMedGoogle Scholar
• Voelkerding KV, Dames SA, Durtschi JD. Next-generation sequencing: from basic research to diagnostics. Clin Chem. 2009;55(4):641–658.
   PubMed Web of Science ®Google Scholar
• Esser D, Holze N, Haag J, et al. Interpreting whole genome and exome sequencing data of individual gastric cancer samples. BMC Genomics. 2017;18(1):517.
   PubMed Web of Science ®Google Scholar
• Nagarajan N, Bertrand D, Hillmer AM, et al. Whole-genome reconstruction and mutational signatures in gastric cancer. Genome Biol. 2012;13(12):R115.
   PubMed Web of Science ®Google Scholar
• Ribeiro-dos-Santos Â, Khayat AS, Silva A, et al. Ultra-deep sequencing reveals the microRNA expression pattern of the human stomach. PLoS ONE. 2010;5(10):e13205.
   PubMed Web of Science ®Google Scholar
• Crosetto N, Mitra A, Silva MJ, et al. Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing. Nat Methods. 2013;10(4):361–365.
   PubMed Web of Science ®Google Scholar
• Alarcón T, Llorca L, Perez-Perez G. Impact of the microbiota and gastric disease development by Helicobacter pylori. In: Tegtmeyer N, Backert S, editors. Molecular pathogenesis and signal transduction by Helicobacter pylori. Cham: Springer International Publishing; 2017. p. 253–275.
   Google Scholar
• Levene MJ, Korlach J, Turner SW, et al. Zero-mode waveguides for single-molecule analysis at high concentrations. Science. 2003;299(5607):682–686.
   PubMed Web of Science ®Google Scholar
• Eid J, Fehr A, Gray J, et al. Real-time DNA sequencing from single polymerase molecules. Science. 2009;323(5910):133–138.
   PubMed Web of Science ®Google Scholar
• Huang KK, Huang J, Wu JKL, et al. Long-read transcriptome sequencing reveals abundant promoter diversity in distinct molecular subtypes of gastric cancer. Genome Biol. 2021;22(1):44.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Oikawa R, Kodaka Y, et al. Cancer-related genetic variants of Helicobacter pylori strains determined using gastric wash-based whole-genome analysis with single-molecule real-time technology. Int J Cancer. 2021;148(1):178–192.
   PubMed Web of Science ®Google Scholar
• Sohn BH, Hwang J-E, Jang H-J, et al. Clinical significance of four molecular subtypes of gastric cancer identified by the cancer genome atlas project. Clin Cancer Res. 2017;23(15):4441–4449.
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhu C, Zhang Y, et al. Molecular analysis of gastric cancer identifies genomic markers of drug sensitivity in Asian gastric cancer. J Cancer. 2018;9(16):2973–2980.
   PubMed Web of Science ®Google Scholar
• Johansson H, Isaksson M, Sörqvist EF, et al. Targeted resequencing of candidate genes using selector probes. Nucleic Acids Res. 2011;39(2):e8.
   PubMed Web of Science ®Google Scholar
• Li J, Lupat R, Amarasinghe KC, et al. CONTRA: copy number analysis for targeted resequencing. Bioinformatics. 2012;28(10):1307–1313.
   PubMed Web of Science ®Google Scholar
• Nadauld LD, Garcia S, Natsoulis G, et al. Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer. Genome Biol. 2014;15(8):428.
   PubMed Web of Science ®Google Scholar
• Myllykangas S, Buenrostro JD, Natsoulis G, et al. Efficient targeted resequencing of human germline and cancer genomes by oligonucleotide-selective sequencing. Nat Biotechnol. 2011;29(11):1024–1027.
   PubMed Web of Science ®Google Scholar
• Ikari N, Serizawa A, Mitani S, et al. Near-comprehensive resequencing of cancer-associated genes in surgically resected metastatic liver tumors of gastric cancer. Am J Pathol. 2019;189(4):784–796.
   PubMed Web of Science ®Google Scholar
• Banerjee J, Mishra N, Dhas Y. Metagenomics: a new horizon in cancer research. Meta Gene. 2015;5:84–89.
   PubMedGoogle Scholar
• Gunathilake M, Lee J, Choi IJ, et al. Alterations in gastric microbial communities are associated with risk of gastric cancer in a korean population: a case-control study. Cancers. 2020;12(9):2619.
   PubMed Web of Science ®Google Scholar
• Hu Y-L, Pang W, Huang Y, et al. The gastric microbiome is perturbed in advanced gastric adenocarcinoma identified through shotgun metagenomics. Front Cell Infect Microbiol. 2018;8(433):1–11.
   PubMed Web of Science ®Google Scholar
• Seol M, Lee YR, Kim KM, et al. The difference of the gut microbiota of gastric cancer in relation to Helicobacter pylori negativity and positivity. J Clin Oncol. 2019;37(4_suppl):10–10.
   Web of Science ®Google Scholar
• Shiroma Y, Takahashi R-U, Yamamoto Y, et al. Targeting DNA binding proteins for cancer therapy. Cancer Sci. 2020;111(4):1058–1064.
   PubMed Web of Science ®Google Scholar
• Leili Sadeghi A, Ali B, Alireza R, et al. An overview of the epigenetic modifications of gene expression in tumorigenesis. Res Mol Med (RMM). 2019;6(3):1–9.
   Google Scholar
• Zhang Y, Yu C. Distinct expression and prognostic values of the replication protein a family in gastric cancer. Oncol Lett. 2020;19(3):1831–1841.
   PubMed Web of Science ®Google Scholar
• Shi S, Zhang Z-G. Role of Sp1 expression in gastric cancer: a meta-analysis and bioinformatics analysis. Oncol Lett. 2019;18(4):4126–4135.
   PubMed Web of Science ®Google Scholar
• Fassan M, Baffa R, Kiss A. Advanced precancerous lesions within the GI tract: the molecular background. Best Pract Res Clin Gastroenterol. 2013;27(2):159–169.
   PubMed Web of Science ®Google Scholar
• Li X, Zheng N-R, Wang L-H, et al. Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer. eBioMedicine. 2021;74:103714.
   PubMed Web of Science ®Google Scholar
• Fassan M, Simbolo M, Bria E, et al. High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers. Gastric Cancer. 2014;17(3):442–449.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu X, Zhang C, et al. Dissecting expression profiles of gastric precancerous lesions and early gastric cancer to explore crucial molecules in intestinal-type gastric cancer tumorigenesis. J Pathol. 2020;251(2):135–146.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Shitara K, Lee J. The right treatment of the right patient: Integrating genetic profiling into clinical decision making in advanced gastric cancer in asia. Am Soc Clin Oncol Educ Book. 2021;(41):1–e73.
   PubMedGoogle Scholar
• Horgan D, Curigliano G, Rieß O, et al. Identifying the steps required to effectively implement next-generation sequencing in oncology at a national level in Europe. JPM. 2022;12(1):72.
   Web of Science ®Google Scholar
• Zhou J, Zhao W, Wu J, et al. Neoantigens derived from recurrently mutated genes as potential immunotherapy targets for gastric Cancer. Biomed Res Int. 2019;2019:8103142.
   PubMed Web of Science ®Google Scholar
• Zhang J, Qiu W, Liu H, et al. Genomic alterations in gastric cancers discovered via whole-exome sequencing. BMC Cancer. 2018;18(1):1270.
   PubMed Web of Science ®Google Scholar
• Pan X, Ji X, Zhang R, et al. Landscape of somatic mutations in gastric cancer assessed using next-generation sequencing analysis . Oncol Lett. 2018;16(4):4863–4870.
   PubMed Web of Science ®Google Scholar
• Ge S, Li B, Li Y, et al. Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing. Am J Cancer Res. 2017;7(7):1540–1553.
   PubMed Web of Science ®Google Scholar